rTMS guided by resting functional magnetic resonance imaging in the treatment of autism spectrum disorders

rTMS guided by resting functional magnetic resonance imaging in the treatment of autism spectrum disorders: Need a sedative

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076036

Enrollment

Unknown

Registered

2023-09-22

Start date

2022-06-30

Completion date

Unknown

Last updated

2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Interventions

Precision positioning group:Transcranial magnetic stimulation guided by fMRI

Classic method group:Transcranial magnetic stimulation guided by "5cm" method

Normal control group:N/A

Eligibility

Sex/Gender

All

Age

9 Years to 16 Years

Inclusion criteria

Inclusion criteria: ? Age 9-16; ? Comply with the diagnostic criteria of autism in the fifth edition of DSM-5; ? CARS scale > 30 points; ? IQ is greater than 70.

Exclusion criteria

Exclusion criteria: Trisomy 21 syndrome; Schizophrenia; Speech and language development disorders; Hearing impairment; History of febrile seizures and seizures; History of craniocerebral injury, craniocerebral infection, brain tumor, etc; History of intracranial metal implantation or intracranial surgery; History of antipsychotic drugs or antiepileptic drugs.

Design outcomes

Primary

Measure	Time frame
Autism-Spectrum Quotient;The Empathy Quotient;Functional Magnetic Resonance Imaging;	—

Countries

China

Contacts

Public Contactzang yu feng

Cognitive and Brain Disease Research Center, Affiliated Hospital of Hangzhou Normal University

zangyf@hznu.edu.cn+86 186 0651 7380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026